Searchable abstracts of presentations at key conferences in endocrinology

ea0029p823 | Endocrine tumours and neoplasia | ICEECE2012

How clinical presentation of insulinoma is changing

Toaiari M. , Davi M. , Boninsegna L. , Falconi M. , Francia G.

Introduction: In 2009 the Endocrine Society’s clinical practice guidelines for management of hypoglycemic disorders, confirming previous suggestions, have stated that the new cut-off of insulin for the diagnosis of insulinoma should be lowed to 3 μU/mL in presence of hypoglycemia (serum glucose ≤55 mg/dL). Moreover hypoglycemia in post-prandial status has been reported in insulinoma, alone or associated with fasting hypoglycemia. Finally preexisting diabetes me...

ea0029p1370 | Pituitary Clinical | ICEECE2012

Sleep apnea in acromegaly: pathogenetic factors and long-term follow up

Castellani C. , Francia G. , Ferrari M. , Viva E. , Davi M.

Background: Sleep apnea syndrome (SAS) is a common disease in acromegaly and it can persist during remission in up to 58% of the patients. Data regarding long term outcome of SAS in acromegalic patients are lacking. Moreover it is still unknown which component, either craniofacial deformation or soft tissue hypertrophy of the palate and upper airways, may play the major role in the pathogenesis of this complication.Aim: To assess the presence of SAS in a...

ea0037ep255 | Calcium and Vitamin D metabolism | ECE2015

PTH 1–34 replacement therapy in post-surgical hypoparathyroidism: preliminary results from the 6-month follow up study

Franchi Antonella , Congedo Valentina , Tina Doris , Raggiunti Gianmarco , Fiore Giuseppe , Raggiunti Bruno

Hypoparathyroidism is characterised by parathyroid hormone (PTH) levels inadequate to maintain plasma calcium concentration within the normal range. Even if the conventional treatment with calcium supplements and active vitamin D analogues is usually able to maintain normocalcemia, episodic low plasma calcium, neuromuscular complaints, renal disease and gastric discomfort are not infrequent. 29 patients with post-surgical hypoparathyroidism were started on PTH 1–34 therap...

ea0029p1828 | Thyroid cancer | ICEECE2012

Ultrasoundelastography: a useful tool to differentiate benign and malignant thyroid nodules?

Congedo V. , Franchi A. , Fiore G. , Raggiunti G. , Di Nicola M. , Ballone E. , Raggiunti B.

Introduction: Ultrasoundelastography (USE) evaluates the tissue elasticity according to the local tissue displacement after a small compression applied by an ultrasound transducer. This technique is based on the concept that a hard lesion is associated to a higher risk of malignancy. The USE has been recently applied for characterization of thyroid nodules. The aim of our preliminary study was to assess the validity of USE for screening benign and malignant thyroid nodules.</p...

ea0014oc5.5 | Thyroid basic | ECE2007

Transcriptional regulation of human type 2 deiodinase and chorionic gonadotropin genes in human placenta: emerging evidence of a common promoter code

Canettieri Gianluca , Santaguida Maria Giulia , Franchi Antonella , Guardia Michele Della , Gulino Alberto , Centanni Marco

Human type 2 deiodinase (hD2) regulates T3 production in placenta during trophoblast development. hD2 mRNA and protein levels are elevated only during the first trimester of gestation then becoming barely detectable. These variations are similar to those of chorionic gonadotropin (hCG), a well-known marker of early gestation secreted by the cytotrophoblast. A peculiar promoter architecture of the gene encoding the alpha subunit of hCG allows a CRE-mediated synergism between cA...

ea0014p590 | (1) | ECE2007

Ghrelin, inhibits AMPK (AMP-dependent protein kinase), a regulator of cell proliferation and metabolism

Leontiou Chrysanthia , Kola Blerina , Dalino Paolo , Salahuddin Nabila , Franchi Giulia , Grossman Ashley , Korbonits Marta

Background Ghrelin stimulates cell proliferation in a number of tissues including pituitary. AMPK, a heterotrimer kinase enzyme, is an important sensor and regulator of cellular energy balance. We have shown that ghrelin can change AMPK activity in various tissues and this mechanism could play a role in its metabolic effects. AMPK has recently been established to strongly inhibit cell proliferation and tumorigenesis. We therefore hypothesised that ghrelin stimulates cell proli...

ea0013p205 | AMEND Young Investigator's Award | SFEBES2007

Ghrelin, a proliferative agent in the pituitary, inhibits AMPK (AMP-dependent protein kinase), an emerging regulator of cell proliferation and metabolism

Leontiou Chrysanthia , Kola Blerina , Dalino Paolo , Salahuddin Nabila , Franchi Giulia , Grossman Ashley , Korbonits Marta

Background: Ghrelin stimulates cell proliferation in a number of tissues including pituitary. AMPK, a heterotrimer kinase enzyme, is an important sensor and regulator of cellular energy balance. We have shown that ghrelin can change AMPK activity in various tissues and this mechanism could play a role in its metabolic effects. AMPK has recently been established to strongly inhibit cell proliferation and tumorigenesis. We therefore hypothesised that ghrelin stimulates cell prol...

ea0011p456 | Endocrine tumours and neoplasia | ECE2006

Prognostic value of KI-67 expression in the cytologic identification of pancreatic endocrine tumors: preliminary data

Manzoni MF , Franchi GM , Piani C , Cappelletti C , Arcidiacono PG , Albarello L , Doglioni C , Bosi E

Background: Organ infiltration and metastasis are the only parameters defining malignancy of pancreatic endocrine tumors. Several studies had demonstrated the prognostic value of Ki-67 expression measured on histological sections obtained from the removed pancreatic endocrine tumors. We postulate that Ki-67 expression measured on fine needle aspiration cytology provides pre-operative indications of the malignancy of pancreatic endocrine tumors.Aim: Aims ...

ea0011p847 | Thyroid | ECE2006

Inhibin B/inhibin binding protein complex is differentially expressed in normal and nodular human thyroid tissue

Della Guardia M , Franchi A , Nardo S , Santaguida MG , Sibilla R , Centanni M

Inhibins A and B, peptides belonging to TGF-ß superfamily, have an ubiquitous antagonist action on activin signalling. In thyroid gland, TGF-ß1 and activin mainly exert an inhibitory action on growth and function. In human thyroid, beside the presence of activin β subunits and its transductional elements (ActRI/II, SMAD), there is no evidence for α subunit expression, an essential component for inhibin A/B gathering (α-ßA/α-ßB), nor for ...

ea0029p80 | Adrenal cortex | ICEECE2012

RRM1 Gene expression affects metabolization and activity of mitotane in adrenocortical cancer cell lines.

Germano A. , Rapa I. , De Francia S. , Volante M. , Laino F. , Duregon E. , Berruti A. , Papotti M. , Terzolo M.

Background: Mitotane (o,p’DDD) is the reference therapy for adrenocortical carcinoma (ACC) and should undergo metabolization in o,p’DDE and o,p’DDA to exert its anti-proliferative activity. We have previously shown that there is a link between RRM1 gene expression and o,p’DDD activity in an adjuvant setting. Aim of this study was to assess whether RRM1 gene expression is correlated to the bioavailability and cytotoxic activity of o,p’DDD and its metabo...